Takeda Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 72
  • Portfolio
  • 26
  • Exits
  • 25
Exits

Takeda Ventures General Information

Description

Founded in 2001, Takeda Ventures is the corporate venture capital arm of Takeda Pharmaceutical Company. The firm's mission is to create strategic growth opportunities for Takeda by building, managing and investing in innovation-based companies. It partners with academic innovators, entrepreneurs and venture investors to create and nurture a portfolio of companies in an array of therapeutic areas, including oncology, gastroenterology and central nervous system disorders.

Contact Information

Formerly Known As
Takeda Research Investment
Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 435 Tasso Street
  • Suite 300
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000

Takeda Ventures Investments (72)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Palleon Pharmaceuticals 17-Sep-2020 Later Stage VC 00000 Drug Discovery Pre-Clinical Trials 000000 0000000 00.0
0000000-000 18-Aug-2020 00000 00000 0000 Biotechnology Generating Revenue
000000000 21-Jul-2020 00000 00000 0000 Pharmaceuticals Clinical Trials - Phase 2
00000000 08-Jul-2020 00000 00000 00000 Biotechnology Generating Revenue 000000 0000000 00.0
00000000 08-May-2020 00000 00000 0000 Biotechnology Generating Revenue 000000 0000000 00.0
000000 00000000000 25-Mar-2020 00000 00000 000.00 Biotechnology Generating Revenue 0000000 000000 00.0
00000 000000000000 02-Mar-2020 00000 00000 00000 Biotechnology Pre-Clinical Trials 000000 0000000 00.0
0000000 13-Feb-2020 00000 00000 Medical Records Systems Generating Revenue 00000 0000000
Emendo Biotherapeutics 15-Jan-2020 Early Stage VC 0000 Biotechnology Generating Revenue 000000 0000000 00.0
Avidity Biosciences 13-Nov-2019 Later Stage VC 00000 Drug Discovery Generating Revenue/Not Profitable 0000000 000000 00.0
You’re viewing 10 of 72 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Takeda Ventures Exits (24)

Company Name Exit Date Exit Type Exit Size
Avidity Biosciences 12-Jun-2020 IPO 00000
0000000 20-Apr-2020 000000000000000000
00000 16-Apr-2020 000000000000000000
000000000 03-Apr-2020 000000000000000000
0000000 0000000000 23-Oct-2019 000000000000000000 0000
000000000 09-May-2019 000 0000
0000000 000000 18-Apr-2019 000 0000
000 00000000000000 04-Apr-2019 000 00000
Outpost Medicine 01-Mar-2019 Out of Business
Bioniz Therapeutics 25-Jan-2019 Merger/Acquisition 0000
You’re viewing 10 of 24 exits. Get the full list »

Takeda Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Takeda Ventures Team (15)

Name Title Deals Funds Boards Office
Alessandra Di Bacco Ph.D Venture Partner 0 Cambridge, MA
David Shaywitz Ph.D Senior Partner Palo Alto, CA
Robbie Woodman Ph.D Senior Partner 00 0 0 London, United Kingdom
Jayson Punwani Ph.D Partner 0 0 0 San Diego, CA
Miles Gerson JD Partner Palo Alto, CA
You’re viewing 5 of 15 team members. Get the full list »